Rocket Doctor AI expands into U.S. market with AI-powered decision support for the patient journey

Proactive - Interviews for investors

Rocket Doctor AI Inc. CEO Dr. Bill Cherniak joined Steve Darling from Proactive’s OTC studio in New York City to discuss the company’s continued growth and expansion into the U.S. healthcare market, where it is revolutionizing how patients access and experience care through AI-driven clinical decision support. Cherniak explained that Rocket Doctor AI integrates AI tools and physician clinical guidelines throughout the patient journey, enabling healthcare professionals to make faster, more accurate decisions and helping doctors establish independent, technology-enabled practices, particularly in rural and underserved areas. Founded out of Cherniak’s own experience as an emergency room physician, the company’s mission is to relieve pressure on hospitals by improving access to care for non-emergency cases. “If we could use technology, diagnostics, and AI tools, we could try to take away some of the administrative burden,” he said, emphasizing that the model blends virtual and in-person care to ensure flexibility and accessibility. Rocket Doctor AI’s growth has been supported by $100,000 in federal funding from Canadian agencies, alongside major traction in the United States. The company is now in-network with Medicaid, Medicare, and several commercial insurers across states including California, New York, and Maryland, giving it access to roughly 7 million covered lives. With its proven ability to blend AI innovation, physician empowerment, and patient-centered care, Rocket Doctor AI is positioning itself as a leader in the next generation of digital healthcare delivery. #proactiveinvestors #rocketdoctorai #cse #aidr #otc #airdf